Significant difference in gut microbiota Bifidobacterium species but not Lactobacillus species in colorectal cancer patients in comparison with healthy volunteers using quantitative real-time PCR
PLOS ONE · 27.11.2024 · 19 (11) · e0294053
DOI: 10.1371/journal.pone.0294053 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 27.11.2024. Verfasst von Fahime Esfandiari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Bifidobacterium, Lactobacillus, Gastrointestinal Microbiome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iran University of Medical Sciences.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Colorectal cancer (CRC), with a growing incidence trend, is one of the most diagnosed cancers and the second cause of cancer-related deaths worldwide. The literature has frequently focused attention on the correlation between the gut microbiota imbalance and CRC. The genera Lactobacillus and Bifidobacterium have recently received increasing attention because of their potential in restoring alterations in the gut microflora. Therefore, this study aimed to quantitatively evaluate the presence of lactobacilli and bifidobacterial strains in the fecal samples of CRC patients compared to healthy volunteers.
Methods
From 2018 to 2019, 25 confirmed CRC patients and 25 age- and gender-matched control subjects were enrolled in the study. Bacterial DNA was extracted from the fecal samples and the presence of lactobacilli and bifidobacterial strains were quantitatively determined using quantitative real-time PCR using genus-specific 16S rDNA primers.
Results
A significant decline in the abundance of bifidobacteria in CRC patients compared to healthy individuals (p value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
- Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Division of Gastroenterology, Department of Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
- Division of Colon and Rectal Surgery, Department of Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Bita Bakhshi
Förderung
- Iran University of Medical Sciences
Zitieren
APA
Esfandiari, F., Bakhshi, B., Shahbazi, T., Derakhshan-Nezhad, E., Bahroudi, M., Minaeeian, S., Boustanshenas, M., Alborzi, F., Behboudi, B., & Fazeli, M. S. (2024). Significant difference in gut microbiota Bifidobacterium species but not Lactobacillus species in colorectal cancer patients in comparison with healthy volunteers using quantitative real-time PCR. PLOS ONE, 19(11), e0294053. https://doi.org/10.1371/journal.pone.0294053
Vancouver
Esfandiari F, Bakhshi B, Shahbazi T, Derakhshan-Nezhad E, Bahroudi M, Minaeeian S, et al. Significant difference in gut microbiota Bifidobacterium species but not Lactobacillus species in colorectal cancer patients in comparison with healthy volunteers using quantitative real-time PCR. PLOS ONE. 2024;19(11):e0294053. doi:10.1371/journal.pone.0294053
BibTeX
@article{Esfandiari2024,
author = {Esfandiari, Fahime and Bakhshi, Bita and Shahbazi, Tayebe and Derakhshan-Nezhad, Elahe and Bahroudi, Mahboube and Minaeeian, Sara and Boustanshenas, Mina and Alborzi, Forough and Behboudi, Behnam and Fazeli, Mohamad Sadegh},
title = {Significant difference in gut microbiota Bifidobacterium species but not Lactobacillus species in colorectal cancer patients in comparison with healthy volunteers using quantitative real-time PCR},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {11},
pages = {e0294053},
doi = {10.1371/journal.pone.0294053}
}
EUVIMED